Espinosa-Jovel, Camilo http://orcid.org/0000-0001-5268-1141
Valencia, Natalia
Gaitán, Lisa
Riveros, Sandra
Article History
Accepted: 30 June 2024
First Online: 23 July 2024
Declarations
:
: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
: Camilo Espinosa-Jovel has served as a paid consultant for the following pharmaceutical companies: Abbott, UCB, Biopas Laboratories, Tecnofarma. Natalia Valencia, Lisa Gaitán, and Sandra Riveros have no conflicts of interest that are directly relevant to the content of this article.
: This study was approved by the institutional ethics committee, with approval number 11 of 2023. We certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: This was a retrospective cohort study based on medical records from our institution. Therefore, the individuals included did not sign an informed consent.
: Not applicable.
: The data that support the findings of this study are available upon reasonable request from the corresponding author.
: Not applicable.
: CE-J: conceived of the presented idea, conceived and designed the analysis, wrote the paper. NV: conceived and designed the analysis, collected the data, contributed data and analysis tools. LG: collected the data. SR: collected the data, contributed data and analysis tools. All authors have read and approved the final version of the manuscript, and agree to be accountable for the work.